Abstract:Objective To investigate the precision and trueness of results from six imported commercial systems for measurement of gamma-glutamyltransferase (GGT) in serum in order to provide reference for the clinical laboratories to verify the target accuracy. Methods Five fresh frozen human serum samples that differed in catalytic concentration were analyzed in two candidate domestic reference laboratories and the target values for GGT were assigned using IFCC reference measurement procedure. The same samples were tested by six commercial systems which were calibrated using the matched calibrator. Each system consisted of five instruments in five laboratories, which had been well maintained before measurement. The data was collected. Precision from the same manufacturer and different manufacturers and biases between target values and mean values from each system were calculated. Results The differences of the mean values for five levels of commercial systems varied from 16. 1% to 35.4%. For the five levels, the coefficients of variation (CVs) of the results from all measurement system were from 5.3% to 8. 8% , and CVs from each level were A 2. 17%- 5.07%, B 4. 21%-10. 98%, C 0. 52%-2. 38%, D 1.35%-2. 59%, E 0. 23%-1..54%-), F 1.83%-2. 38%. Biases between the mean values of each commercial systems and the target values were A 0. 43% -8.41% ), B -1.49% - -13.04% ), C 11.20% -17.73% ), D 0. 19% -4. 62% ), E -0. 30% - -2. 63% ), F 4). 46%-7.90%, respectively. The investigation showed that biases of two manufacturers were less than a quarter of the total allowable error (TAE) of The Clinical Laboratory Improvement Amendments of 1988 (CLIA'88) in the whole range of investigated concentrations and the other two manufacturers' biases could meet a quarter of TAE in a relative limited range. The biases of two manufacturers were near or more than half of TAE in most levels. It also revealed that the biases of more than half of manufacturers were more than a quarter of TAE in the low or high level of investigated concentrations. Conclusions The mean values of each manufacturer were significantly different. The variances of commercial systems from different manufacturers were much higher than those from the same manufacturer. Some imported commercial systems for measurement GGT should be better calibrated with the reference method, especially in the whole measurement linearity.

Proficiency testing on determination of 6 kinds of liver function indices

Study on the Relationship Between Different Patterns of Nonalcoholic Fatty Liver Disease and the Levels of TNF-α and IL-6

Research for the Reference Ranges of 36 Physicochemical Indexes in the Serum of Healthy Individuals in Hangzhou

Quality Assurance of Clinical Biochemistry Testing:A Mualti-Center Study Based Reference Interval for Clinical Chemistry Tests in the Chinese Population

Non-ALT Biomarkers for Markedly Abnormal Liver Histology among Chinese Persistently Normal Alanine Aminotransferase-Chronic Hepatitis B Patients.

First Definition Of Reference Intervals Of Liver Function Tests In China: A Large-Population-Based Multi-Center Study About Healthy Adults

Evaluation of serum electrolytes measurement through the 6-year trueness verification program in China

Establishment and evaluation of the reference methods of alanine aminotransferase and aspartate aminotransferase

Determination of Serum Carbohydrate-Deficient Transferrin in the Diagnosis of Alcoholic Liver Disease.

Establishing Reference Intervals of the Routine Laboratory Tests for Hepatorenal Function in Shanghai by Biochemistry

Comparison of measurements for ALT and AST among four domestic reference laboratories

Proteomic Analysis of Individual Variation in Normal Livers of Human Beings Using Difference Gel Electrophoresis

Simultaneous quantification of six proteins related to liver injury using nano liquid chromatography–tandem mass spectrometry

Complementary Laboratory Indices for Predicting the Disease Status of Patients with Hepatitis B Virus Infection

Application of reference methods suggested by IFCC and analysis of the 2006 ring trial results

Evaluation of blood lead measurements by the 6-year external quality assessment program in China

[The Diagnostic Value of Eight Serum Indices for Liver Fibrosis].

Study of Result Inter-Accreditation for Routine Clinical Chemistry Items in Shanghai

Establishment of Interleukin‐18 Time‐resolved Fluorescence Immunoassay and Its Preliminary Application in Liver Disease

Investigation of precision and trueness of results from the imported commercial systems for measurement of gamma-glutamyitransferase in serum

Five different levels of secondary standard reference material of transaminase prepared with mixed freezing human serum